Ronna Dornsife

Ronna Dornsife, M.S., currently serves as the Manager of the Upstream Team in Pre-Clinical Manufacturing of Viral Vectors at Asklepios BioPharmaceutical, Inc., having joined the company in March 2023. With a background in cell biology, instructional technology, and biotechnology, Ronna has extensive experience in pre-clinical viral vector production, large molecule bioprocessing, and flow cytometry. Previously, Ronna held roles at organizations such as BRITE at North Carolina Central University, the University of North Carolina at Chapel Hill, and United Therapeutics, contributing to research in gene therapies, regenerative medicine, and toxicology. Ronna earned a Master of Science in Pathology/Experimental Pathology from Colorado State University and a Bachelor of Science in Genetics from The Ohio State University.